财通证券股份有限公司 会 议 文 件 公司地址：浙江省杭州市西湖区天目山路198号财通双冠大厦 目 录 会议议程 2 会议须知 4 -1- 会议议程 现场会议开始时间：2025 年 6 月 19 日（星期四）上午 9:30 现场会议召开地点：杭州市西湖区天目山路198 号财通双冠大厦西楼1102 会议室 现场会议日程： 一、宣布会议开始，介绍与会股东、来宾情况 （宣布出席现场会议的股东人数及其代表的股份总数） -2- -3- 会议须知 为维护股东的合法权益，确保股东在本次股东大会期间依法行使权利， 保证本次股东大会的正常秩序和议事效率，依据中国证监会《上市公司股 东会规则》及本公司《章程》《股东大会议事规则》的有关规定，本公司 特通知如下： 一、本次会议期间，全体参会人员应以维护股东的合法权益、确保会 议的正常秩序和议事效率为原则，依法行使权利、认真履行义务。 二、为保证会议的严肃性和正常秩序，除参加现场会议的股东及股东 代理人（以下简称"股东"）、董事、监事、高级管理人员、公司聘请的 律师及公司董事会认可的人员以外，公司有权依法拒绝其他人士入场，对 于干扰会议秩序、侵犯股东合法权益的行为，公司有权予以制止并 ...

Core Insights - The 47th Annual Conference of the European Accounting Association highlighted the importance of corporate governance and sustainable development in the context of internationalization for Chinese enterprises [1] - The increasing complexity of the international environment poses significant challenges for Chinese companies, making corporate governance a critical factor in managing cross-border operational risks [1] Policy and Legal Risks - The EU has established a systematic investment review mechanism for Chinese investments, and trade protection tools are continuously evolving [2] - The introduction of the concept of "serious distortion" into trade remedy tools signifies a shift in the EU's approach to trade with China [2] - Compliance risks for European companies have expanded beyond financial and operational compliance to include systematic ESG (Environmental, Social, and Governance) compliance requirements [2] Risk Management Strategies - Companies are advised to adopt proactive measures in corporate governance and risk control, such as localizing governance structures and enhancing ESG governance concepts [2] - Establishing a comprehensive risk management system is essential for evaluating and monitoring overseas risks [3] Governance Structure and Risk Assessment - Companies should strategically select entry modes and design equity structures based on the risk levels of target countries to minimize overseas governance risks [3] - A robust overseas governance risk assessment system should be established to regularly identify and analyze risk factors, ensuring real-time monitoring and feedback [3] Compliance and Internal Control - A tiered compliance management system is necessary to ensure adherence to international rules and local laws, preventing significant losses from violations [4] - Effective internal controls and dynamic risk warning mechanisms are crucial for safeguarding assets and ensuring operational stability in international markets [4] Conclusion - Chinese enterprises need to transition from merely exporting products to exporting governance, creating a governance system that balances efficiency, compliance, and cultural recognition [4] - Institutions like the University of International Business and Economics are actively contributing to research and providing intellectual support for Chinese companies' internationalization efforts [4]

Group 1: Zhejiang Special Bonds for Real Estate - Zhejiang and Sichuan issued special bonds totaling 19.2 billion yuan for the acquisition of existing residential properties, with Zhejiang's issuance at 17.5 billion yuan, accounting for 3.2% of its new special bonds [1] - The acquisition projects involve 11 projects, with 7 owned by local state-owned enterprises, 2 by mixed-ownership enterprises, and 2 by private enterprises [1] - This initiative aims to alleviate real estate inventory pressure and stabilize market expectations, providing a new approach for high-inventory third and fourth-tier cities [1] Group 2: Vanke's Stock Sale - Vanke announced the sale of 22 million A-shares, representing 0.18% of its total share capital, raising approximately 1.458 billion yuan [2] - The shares were sold at an average price of 6.63 yuan per share, lower than the repurchase cost, indicating a book loss but significant for Vanke's liquidity [2] - This move is part of a 2022 repurchase plan and aims to alleviate cash flow pressures faced by real estate companies [2] Group 3: Independent Director of Nandu Property - Nandu Property announced the removal of independent director Gao Qiang due to his detention by supervisory authorities, proposing Zhao Rongxiang as the new independent director [3] - This incident may raise market concerns regarding corporate governance and prompt other companies in the property sector to review their governance structures [3] Group 4: Gujia Home's Share Freeze - Gujia Home reported that all shares held by Gujia Group (12.55% of total shares) and TB Home (5.01% of total shares) have been frozen and marked judicially [4] - The company clarified that this situation will not change its control or affect daily operations, but may raise concerns about potential debt risks and the stability of its equity structure [4] - Other companies in the home furnishing sector may adopt more cautious approaches to capital and equity management due to this event [4] Group 5: Jianfa's Loan to Jianfa Real Estate - Jianfa announced a loan of 2 billion yuan to its subsidiary Jianfa Real Estate, with a term from June 10, 2025, to July 9, 2025, at an interest rate of 4.5% [5] - This loan aims to support the development of Jianfa Real Estate's business and is considered manageable in terms of operational risk [5] - The funding will help alleviate liquidity pressures in the real estate sector and support project advancement and operations [5]

Core Points - Jinshang Bank reported a net profit of 1.75 billion yuan for 2024, marking a 12.6% decrease year-on-year, the first decline since its listing [1][2] - The bank's total operating income for 2024 was 5.791 billion yuan, down 0.2% from the previous year, indicating a reversal from previous growth trends [1][2] - The bank's non-performing loan (NPL) ratio stood at 1.77% at the end of 2024, remaining stable year-on-year, but the NPL rate in the manufacturing sector surged from 0.75% to 2.83% [1][4] Financial Performance - Jinshang Bank's pre-provision profit for 2024 was 3.521 billion yuan, an increase of 0.55 billion yuan year-on-year [2] - The bank's credit impairment losses for 2024 were 1.675 billion yuan, up 243 million yuan from the previous year, contributing to the decline in net profit [2] - The average return on total assets and average return on equity for 2024 were 0.47% and 6.88%, respectively, both showing a decline compared to the previous year [3] Asset Quality - The total amount of loans and advances issued by Jinshang Bank reached 201.414 billion yuan at the end of 2024, with corporate loans growing by 5.8% and personal loans by 7.7% year-on-year [4] - The bank's focus on non-performing loans revealed a significant increase in the manufacturing sector, with the NPL balance rising from 328 million yuan to 1.128 billion yuan [4] - The bank's provision coverage ratio was 205.46% at the end of 2024, reflecting a strong risk resistance capability [5] Governance Changes - Jinshang Bank announced significant changes to its board of directors, including the nomination of new non-executive and independent directors [5][6] - The bank plans to enhance its financial management and internal compliance controls as part of its governance strategy [6] - The decision to abolish the supervisory board aims to streamline decision-making processes and improve governance efficiency [6]

Financial Data and Key Metrics Changes - The meeting reported that proxies were received for approximately 321.7 million of the 415.5 million shares of common stock outstanding, representing about 77% of the total shares, which constitutes a quorum for the meeting [6]. Business Line Data and Key Metrics Changes - No specific data on business lines or key metrics changes were provided in the meeting. Market Data and Key Metrics Changes - No specific market data or key metrics changes were discussed during the meeting. Company Strategy and Development Direction and Industry Competition - The company is focused on evaluating and refining its executive compensation program based on stockholder feedback, indicating a commitment to aligning management incentives with shareholder interests [14]. Management's Comments on Operating Environment and Future Outlook - Management acknowledged the nonbinding nature of the advisory vote on executive compensation and emphasized that the board will seriously consider the feedback received from stockholders [14]. Other Important Information - The proposal for the approval on an advisory basis of the compensation of named executive officers did not pass, which may influence future compensation strategies [14]. - The final voting results will be reported in a current report on Form 8-K to be filed with the SEC within four business days after the meeting [15]. Q&A Session Summary - There were no questions from stockholders during the meeting, indicating a lack of immediate concerns or inquiries from the attendees [12].

Financial Data and Key Metrics Changes - The preliminary results indicate that all nominees for the Board of Directors have been elected, and the ratification of Deloitte as the independent auditors for the current fiscal year has passed [11] - The compensation of named executive officers has been approved [11] Business Line Data and Key Metrics Changes - No specific data or metrics related to individual business lines were discussed in the meeting [10] Market Data and Key Metrics Changes - No specific market data or metrics were provided during the meeting [10] Company Strategy and Development Direction and Industry Competition - The meeting focused on the election of directors and the approval of auditor selection, with no detailed discussion on company strategy or competitive positioning [9][10] Management's Comments on Operating Environment and Future Outlook - Management did not provide specific comments on the operating environment or future outlook during this meeting [10] Other Important Information - The meeting was conducted virtually, and stockholders were able to submit questions through a text box on the virtual meeting screen [8] - A complete list of stockholders entitled to vote was available online [5] Q&A Session Summary - There were no questions submitted during the Q&A session [10]

Duolingo (DUOL) FY 2025 Annual General Meeting June 11, 2025 11:30 AM ET Speaker0 Good morning. I am Luis Von Anh, cofounder, chief executive officer, and chairman of the board of directors of Duolingo, Inc. I am very happy to welcome you to our twenty twenty five annual meeting of stockholders. On behalf of Duolingo, the members of the board, and the company's management, I want to thank you for joining us today. With me is Steve Chen, the company's General Counsel and Secretary, who will serve as Secretar ...

Core Insights - BIC has appointed Rob Versloot as the new CEO, effective September 15, 2025, following a thorough selection process by the Board of Directors [2][3] - The transition period will involve close collaboration between the outgoing CEO Gonzalve Bich and Rob Versloot to ensure business continuity [4] - Rob Versloot brings extensive experience in the FMCG sector, having successfully led transformations and growth in previous roles, particularly at Hero Group [6] Company Overview - BIC is a global leader in stationery, lighters, and shavers, with a presence in over 160 countries and a workforce of more than 13,000 employees [10] - The company is recognized for its commitment to sustainability and education, and its product portfolio includes iconic brands such as BIC® 4-Color™, Cristal®, and Tangle Teezer® [10] - BIC is listed on Euronext Paris and included in the SBF120 and CAC Mid 60 indexes, highlighting its significant market presence [10] Leadership Transition - Edouard Bich, Chair of the Board, expressed optimism about the new chapter of growth and innovation under Rob Versloot's leadership [5] - Rob Versloot emphasized his commitment to building on the legacy of Gonzalve Bich and focusing on consumer needs and sustainable innovation [5]

Group 1 - The company held its 22nd meeting of the third board of directors on June 10, 2025, with all seven directors present, complying with relevant laws and regulations [1][2] - The board approved the nomination of four candidates for the fourth board of non-independent directors, with a term of three years starting from the approval date by the shareholders' meeting [2][3] - The board also approved the nomination of four candidates for the fourth board of independent directors, with the same term conditions as the non-independent directors [2][3] Group 2 - The company decided to abolish the supervisory board and amend its articles of association to enhance corporate governance, with the supervisory board's powers being transferred to the audit committee of the board [3][4] - The board approved the formulation and revision of several internal governance systems to align with the latest amendments to the articles of association and relevant regulations [4] - A proposal was made to convene the second extraordinary general meeting of shareholders in 2025 on June 27, 2025, which was also approved by the board [4][5]

Core Points - The company, He Yuan Biotechnology (Shanghai) Co., Ltd., was established as a joint-stock company in accordance with the Company Law of the People's Republic of China and is registered with the Shanghai Municipal Market Supervision Administration [1][2] - The company was approved by the Shanghai Stock Exchange on November 4, 2021, and registered with the China Securities Regulatory Commission on January 11, 2022, for its initial public offering of 100 million shares, which were listed on the STAR Market on March 22, 2022 [2] - The registered capital of the company is RMB 649.0367 million [2] - The company aims to develop high-tech industries and expand both domestic and international markets while ensuring reasonable returns for shareholders and creating positive social effects [6] Company Structure - The company is a permanent joint-stock company, with the board of directors acting as the legal representative [2][3] - The legal representative is responsible for civil activities conducted in the company's name, and the company bears civil liability for actions taken by the legal representative [3] - Shareholders are liable for the company's debts only to the extent of their subscribed shares, while the company is liable for its debts with all its assets [3] Business Operations - The company's business scope includes drug production, entrusted drug production, and various technical services in the biomedical field [6] - The company operates under principles of honesty and legality, aiming to optimize management and develop high-tech industries [6] Share Issuance and Management - The company issues registered shares, all of which are ordinary shares, with a total of 649.0367 million shares issued [7] - The shares are stored in a centralized manner at the Shanghai branch of China Securities Depository and Clearing Corporation Limited [7] - The company can increase its registered capital through various methods, including issuing shares to unspecified or specific objects, subject to shareholder approval [9] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, voting, and other benefits proportional to their shareholdings [15] - Shareholders are required to comply with laws and the company's articles of association, and they cannot withdraw their capital except as permitted by law [20] - The company has provisions for shareholders to propose and vote on various matters, including the election of directors and approval of financial reports [23][29] Governance and Meetings - The company holds annual and extraordinary shareholder meetings, with specific procedures for calling and conducting these meetings [48][52] - The board of directors is responsible for convening shareholder meetings and ensuring compliance with legal and regulatory requirements [52][54] - Shareholder meetings must be documented, and records must be maintained for a minimum of 10 years [78]